FDA Inspection 776652 — Eurofins BioPharma Product Testing Toronto, Inc.
The FDA completed an inspection of Eurofins BioPharma Product Testing Toronto, Inc. on March 27, 2012 in North York. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 27, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- North York (Canada)